Glaukos CorporationGKOSNYSE
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 88% recommend buying.

Consensus Rating
Buy
16 analysts·Moderate coverage
88%
Rating Distribution
Strong Buy
00%
Buy
1488%
Hold
16%
Sell
16%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 28, 2026BTIG
Glaukos price target raised to $131 from $123 at BTIG
Target:$131.00
+4.4%from $125.46
Jan 22, 2026Stifel Nicolaus
Glaukos price target raised to $160 from $115 at Stifel
Target:$160.00
+28.9%from $124.16
Jan 14, 2026Piper Sandler
Piper Sandler on Glaukos Corporation (GKOS): 'Strong Q4 Print Overshadowed Some By iDose Buy-Side Bogey'
Target:$165.00
+64.0%from $100.61
Jan 9, 2026Goldman Sachs
Glaukos price target raised to $138 from $112 at Goldman Sachs
Target:$138.00
+20.9%from $114.15
Jan 2, 2026Stephens
Glaukos price target raised to $145 from $115 at Stephens
Target:$145.00
+28.4%from $112.91
Dec 23, 2025UBS
Glaukos price target raised to $145 from $140 at UBS
Target:$145.00
+23.8%from $117.09
Dec 18, 2025Truist Financial
Glaukos price target raised to $145 from $120 at Truist
Target:$145.00
+25.2%from $115.85
Dec 17, 2025UBS
Piper Sandler on Glaukos Corporation (GKOS): 'Our 2026 Top Idea'
Target:$165.00
+45.0%from $113.76
Dec 17, 2025Piper Sandler
Piper Sandler on Glaukos Corporation (GKOS): 'Our 2026 Top Idea'
Target:$61.00
-46.4%from $113.76
Dec 9, 2025Needham
Glaukos price target raised to $125 from $117 at Needham
Target:$125.00
+14.9%from $108.82
Nov 10, 2025UBS
UBS Reiterates Buy Rating on Glaukos Corporation (GKOS)
Target:$140.00
+62.4%from $86.22
Oct 30, 2025Truist Financial
Truist on Glaukos Corporation (GKOS): 'Strong 3Q Beat Led by iDos'
Target:$120.00
+24.0%from $96.81
Oct 30, 2025BTIG
Glaukos price target raised to $116 from $104 at BTIG
Target:$116.00
+50.5%from $77.09
Oct 30, 2025Wells Fargo
Glaukos price target raised to $122 from $120 at Wells Fargo
Target:$122.00
+58.3%from $77.09
Oct 30, 2025Needham
Glaukos Corporation (GKOS) PT Raised to $117 at Needham
Target:$117.00
+51.8%from $77.09
Oct 27, 2025Stifel Nicolaus
Glaukos Corporation (GKOS) Can Grow Revenue 30%+ for Years With Epioxa- Stifel
Target:$115.00
+54.0%from $74.67
Oct 13, 2025BTIG
Glaukos price target lowered to $104 from $118 at BTIG
Target:$104.00
+26.0%from $82.56
Oct 1, 2025Goldman Sachs
Glaukos initiated with a Buy at Goldman Sachs
Target:$103.00
+26.3%from $81.55
Jul 31, 2025Mizuho Securities
Glaukos price target lowered to $130 from $150 at Mizuho
Target:$130.00
+38.2%from $94.05
May 1, 2025Truist Financial
Glaukos price target lowered to $135 from $140 at Truist
Target:$135.00
+61.6%from $83.54
Dec 31, 2024Stifel Nicolaus
Glaukos price target raised to $175 from $153 at Stifel
Target:$175.00
+16.7%from $149.94
Dec 18, 2024Truist Financial
Glaukos price target raised to $185 from $152 at Truist
Target:$185.00
+27.5%from $145.14
Dec 2, 2024Stifel Nicolaus
Glaukos Corporation (GKOS) PT Raised to $153 at Stifel
Target:$153.00
+9.1%from $140.18
Dec 2, 2024Morgan Stanley
Morgan Stanley Downgrades Glaukos Corporation (GKOS) to Underweight
Target:$120.00
-14.8%from $140.80
Nov 5, 2024Needham
Needham Reiterates Buy Rating on Glaukos Corporation (GKOS)
Target:$149.00
+16.9%from $127.45